Any current/future new fundraising through debt or equity?

There is no explicit mention of any current or future fundraising plans through debt or equity in the provided transcript of the call. The company discusses acquisitions and integrations but does not indicate raising capital through debt or equity. Dividend policy remains focused on paying dividends up to 75% of current year's net profits and 25% of previous year's reserves, indicating confidence in cash flow but no mention of additional fundraising. The CFO and management did not comment on new fundraising activities during the Q&A or opening remarks. Overall, no direct indication of plans fo

Any current/future capex/capital investment/strategic investment?

No specific details on current or future capital expenditure (capex) or strategic capital investments are mentioned on page 16 or in the surrounding Q&A section. The discussion focuses more on integration efforts of acquisitions like Raksha and Mayfair We Care, technology integrations (e.g., with National Health Claims Exchange - NHCX), and operational synergies. Integration of acquisitions is expected to take 3-4 quarters for full synergy and cost rationalization, implying some ongoing investment in this area. There is no explicit mention of large-scale capital investments or future capex pla

Future growth expectations in sales/revenue/volumes?

Medi Assist expects revenue growth to be in line with industry growth for FY25 and FY26. (Page 13) Premium under management grew by 35.7% YoY to Rs.14,163 crores, with group segment growing by 34.5% and retail by 45%. (Page 4) The company anticipates stable yields without significant compression in the near term, supported by a mix of products served. (Page 15) Growth after acquisitions is considered organic as acquired businesses renew policies and integrate fully. (Page 10) Continued expansion of network and technology integration is expected to drive volume growth and enhanced cashless pene

Future growth expectations in earnings/operating earnings/profits/EPS?

The company expects revenue growth to be in line with industry growth for FY'25 and FY'26, indicating steady top-line expansion. Margins have been maintained around 20-21% EBITDA margin despite ongoing integration costs from acquisitions, with synergies expected to improve margins over the next few quarters. Profit margins have been stable at approximately 12.5%-13.8% range in recent quarters and periods. Integration-related one-time expenses are expected to taper off over the next 3-4 quarters, leading to cost rationalization and margin improvement. The company has a history of consistent div

Medi Assist Healthcare Services LtdQ3 FY24Insurance

Medi Assist Healthcare Services Ltd Q3 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹297.9P/E: 22.5Market Cap: ₹2.2K CrSector: Insurance

Management growth scorecard

Revenue

Category 2

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

N/A

0 of 2 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 2

Medi Assist expects revenue growth to be in line with industry growth for FY25 and FY26. (Page 13)
Premium under management grew by 35.7% YoY to Rs.14,163 crores, with group segment growing by 34.5% and retail by 45%. (Page 4)
The company anticipates stable yields without significant compression in the near term, supported by a mix of products served. (Page 15)
Growth after acquisitions is considered organic as acquired businesses renew policies and integrate fully. (Page 10)
Continued expansion of network and technology integration is expected to drive volume growth and enhanced cashless penetration. (Pages 4, 16)
The company sees opportunities to grow alongside market trends and maintain or increase market share, benefiting from the growing TPA share in health premiums. (Page 8, 13)
Integration of acquisitions like Raksha and Mayfair We Care is expected to complete over 4 quarters, stabilizing margins and enhancing profitability. (Pages 7, 12)

Margin guidance

Category 3

The company expects revenue growth to be in line with industry growth for FY'25 and FY'26, indicating steady top-line expansion.
Margins have been maintained around 20-21% EBITDA margin despite ongoing integration costs from acquisitions, with synergies expected to improve margins over the next few quarters.
Profit margins have been stable at approximately 12.5%-13.8% range in recent quarters and periods.
Integration-related one-time expenses are expected to taper off over the next 3-4 quarters, leading to cost rationalization and margin improvement.
The company has a history of consistent dividend payouts and plans to continue dividend payments, reflecting sustainable cash flows.
Return ratios like ROCE and ROE have declined slightly compared to previous periods but are expected to stabilize as synergies from acquisitions mature.
Organic growth remains strong post-acquisitions with continued addition of new corporate accounts and insurer relationships supporting earnings growth.

See what Medi Assist Healthcare Services Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

There is no explicit mention of any current or future fundraising plans through debt or equity in the provided transcript of the call.
The company discusses acquisitions and integrations but does not indicate raising capital through debt or equity.
Dividend policy remains focused on paying dividends up to 75% of current year's net profits and 25% of previous year's reserves, indicating confidence in cash flow but no mention of additional fundraising.
The CFO and management did not comment on new fundraising activities during the Q&A or opening remarks.
Overall, no direct indication of plans for fresh fundraising through debt or equity is mentioned in the available information.

Order book

The transcript does not explicitly mention current or expected orderbook or pending orders for Medi Assist Healthcare Services Limited. However, related operational insights include: - The company has a contract liability of Rs.206 crores as of December 2023, which is amortized monthly as policies renew. - Government segment contracts are typically fixed tenure projects, resulting in subcontracting costs aligned with contract durations. - Integration efforts of recent acquisitions like Raksha TPA are ongoing, with expectations of synergy benefits over the coming quarters. - The company continues to add new corporate accounts and insurer relationships, indicating ongoing business growth and renewal. - Medi Assist is fully integrated with National Health Claims Exchange (NHCX), positioning it for improved cashless claims processing and operational efficiency. No direct quantitative data on specific orderbooks or pending orders is provided in the available pages.

See what Medi Assist Healthcare Services Ltd management said on order book — free account, 30 seconds.

Capex plans

No specific details on current or future capital expenditure (capex) or strategic capital investments are mentioned on page 16 or in the surrounding Q&A section.
The discussion focuses more on integration efforts of acquisitions like Raksha and Mayfair We Care, technology integrations (e.g., with National Health Claims Exchange - NHCX), and operational synergies.
Integration of acquisitions is expected to take 3-4 quarters for full synergy and cost rationalization, implying some ongoing investment in this area.
There is no explicit mention of large-scale capital investments or future capex plans during the call.
The company appears focused on leveraging technology and acquisitions to enhance service capabilities rather than specifying new capital expenditure projects.

Track Medi Assist Healthcare Services Ltd — get its next earnings analysis in your feed

How does Medi Assist Healthcare Services Ltd rank vs peers in Insurance?

Pro feature

ThisMedi Assist Healthcare Services Ltd

Rev 2Mar 3

See where Medi Assist Healthcare Services Ltd sits in InsuranceSee which companies these are, and every other name in the sector.Open rankings

How does Medi Assist Healthcare Services Ltd rank in Insurance?

Compare Medi Assist Healthcare Services Ltd against every Insurance company (Q3 FY24) on revenue, margins and earnings-call signals.

View Insurance leaderboard →

What Medi Assist Healthcare Services Ltd's management said in earlier quarters

Others in Insurance this season

SBI Life Insurance Company Ltd (Q2 FY27)
For the quarter ended September 30, 2026, SBI Life Insurance reported premium received from policyholders of ₹48,97,583 lakhs compared to ₹44,07,462 lakhs for…
Star Health & Allied Insurance Company Ltd (Q2 FY27)
Insurance Revenue for Q2 FY27: ₹5,074 Cr, a 15% YoY increase from ₹4,396 Cr in Q2 FY26 (Page 7). Key investor presentation takeaways from Star Health & Allied I
HDFC Life Insur. (Q3 FY26)
Profit after tax (PAT) grew 7% to Rs. Key concall takeaways from HDFC Life Insurance Company Ltd's Q3 FY26 earnings call — and how it ranks against sector…
Max Financial Services Ltd (Q4 FY26)
Total APE (Annualized Premium Equivalent) for FY’26: Rs 10,502 crore, up 20% YoY from Rs 8,770 crore in FY’25 (Page 4). Key investor presentation takeaways from

Compare:vs Life Insurance vs SBI Life Insurance Company Ltd vs HDFC Life Insur.

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →